[1] LI XQ, ZHENG X, CHEN M, et al. Characteristics of diabetic nephropathy patients without diabetic retinopathy: A retrospective observational study[J].Medicine (Baltimore),2017,96(18):e6805. [2] 钟玉玲.糖化血红蛋白变异指数与糖尿病慢性并发症发生风险的相关性研究[J].中国全科医学,2020,23(3):276-280. [3] FANG Z, DENG J, WU Z, et al. Cystatin C Is a Crucial Endogenous Protective Determinant Against Stroke[J].Stroke,2017,48(2):436-444. [4] 中华医学会内分泌学分会.中国成人糖尿病肾脏病临床诊断的专家共识[J].糖尿病临床,2016,10(6):243-253. [5] LEE W J, SOBRIN L, LEE M J, et al. The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3)[J].Invest Ophthalmol Vis Sci,2014,55(10):6547-6553. [6] AHMED M H, ELWALI E S, AWADALLA H, et al. The relationship between diabetic retinopathy and nephropathy in Sudanese adult with diabetes: population based study[J].Diabetes Metab Syndr,2017,11 Suppl 1:S333-S336. [7] ZHANG J, WANG Y, LI L, et al. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy[J].Ren Fail,2018,40(1):243-251. [8] 吴显川,王远桥,李林敏, 等.胱抑素C、高敏C反应蛋白、尿酸水平检测对脑小血管病的临床意义[J].医学临床研究,2019,36(12):2349-2351. [9] 刘玉珊.老年动脉粥样硬化性心肌梗死患者血清胱抑素C水平与血管内皮细胞损伤相关性研究[J].陕西医学杂志,2020,49(4):431-434. [10] 蒋飞霞,苏宏业,潘海林, 等.2型糖尿病患者规范治疗后合并糖尿病视网膜病变及糖尿病肾病的情况及其影响因素[J].广西医学,2018,40(7):775-777. [11] 吴卫云,高姚怡,吴炯, 等.糖化白蛋白与糖尿病视网膜病变、糖尿病肾病及糖尿病周围神经病变的相关性[J].复旦学报(医学版),2018,45(4):473-477.
2021, Vol. 38 
